Tandem Diabetes Profit Pressured by Shift to Subscription Model
TNDM earnings face scrutiny as transition to pay-as-you-go insulin delivery impacts near-term margins and revenue growth. Tandem Diabetes Care reported a 12% year-over-year revenue increase to $245 million in Q2, but gross margins fell 300 basis points to 52% due to its ne